Back to CYTK

Affinity Asset Advisors, LLC → CYTK

Affinity Asset Advisors, LLC CYTK Position History

Cytokinetics, Incorporated • Healthcare

Quarters held
4
Latest value
$49.4M
Q3 2026
Peak value
$50.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$50.8M
Q1 2026$46.2M
Q2 2026$46.9M
Q3 2026$49.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$49.4M750.0K——
Q2 2026$46.9M550.0K——
Q1 2026$46.2M700.5K——
Q4 2025$50.8M800.0K——

Other funds holding CYTK

Other Affinity Asset Advisors, LLC positions

ROIV

ROIVANT SCIENCES LTD

$132.7M
APGE

APOGEE THERAPEUTICS INC

$131M
ROIV

ROIVANT SCIENCES LTD

$117M
SYRE

SPYRE THERAPEUTICS INC

$113.9M
SYRE

SPYRE THERAPEUTICS INC

$113.6M
APGE

APOGEE THERAPEUTICS INC

$108.2M
XENE

XENON PHARMACEUTICALS INC

$97.4M
XENE

XENON PHARMACEUTICALS INC

$96.3M